Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Carcinogenesis

• Publication date

  1999-11-01

• Fields of study

  Biology, Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/CARCIN/20.11.2101PMID 10545412
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model.

  1999cited by this paper
• A review of plants used in the treatment of liver disease: part two.

  1999cited by this paper
• Human salivary tea catechin levels and catechin esterase activities: implication in human cancer prevention studies.

  1999cited by this paper
• Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression.

  1998cited by this paper
• A review of plants used in the treatment of liver disease: part 1.

  1998cited by this paper
• Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.

  1998cited by this paper
• Synchronized proliferation induced by 12-O-tetradecanoylphorbol-13-acetate treatment of mouse skin: an in vivo model for cell cycle regulation.

  1998cited by this paper
• Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes.

  1998cited by this paper
• A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.

  1998cited by this paper
• Natural antioxidants in chemoprevention.

  1998cited by this paper
• Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens.

  1997cited by this paper
• Absorption, distribution, elimination of tea polyphenols in rats.

  1997cited by this paper
• Polyphenols as inhibitors of carcinogenesis.

  1997cited by this paper
• Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea

  1997cited by this paper
• Mechanism of differential efficacy of garlic organosulfides in preventing benzo(a)pyrene-induced cancer in mice.

  1997cited by this paper
• Novel cancer chemopreventive effects of a flavonoid antioxidant silymarin: inhibition of mRNA expression of an endogenous tumor promoter TNF alpha.

  1997cited by this paper
• Protective effects of silymarin against photocarcinogenesis in a mouse skin model.

  1997cited by this paper
• An Overview of Chemoprevention: Current Status and Future Prospects

  1997cited by this paper
• Risk biomarkers and current strategies for cancer chemoprevention

  1996cited by this paper
• The NF-kappaB transcription factor in oncogenesis.

  1996cited by this paper
• Skin cancer chemoprevention.

  1996cited by this paper
• Diet intervention for modifying cancer risk.

  1996cited by this paper
• Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.

  1995cited by this paper
• Two high-performance liquid chromatographic assays for the determination of free and total silibinin diastereomers in plasma using column switching with electrochemical detection and reversed-phase chromatography with ultraviolet detection.

  1995cited by this paper
• Pharmacokinetics of silybin following oral administration of silipide in patients with extrahepatic biliary obstruction.

  1994cited by this paper
• Plasma concentrations of free and conjugated silybin after oral intake of a silybin-phosphatidylcholine complex (silipide) in healthy volunteers.

  1994cited by this paper
• Inhibitory effect of silymarin, an anti-hepatotoxic flavonoid, on 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity and mRNA in SENCAR mice.

  1994cited by this paper
• Lipid peroxidation.

  1993cited by this paper
• Cancer chemoprevention: principles and prospects.

  1993cited by this paper
• Lipid peroxidation and irreversible damage in the rat hepatocyte model. Protection by the silybin-phospholipid complex IdB 1016.

  1992cited by this paper
• Inhibition of skin tumor promoter-caused induction of epidermal ornithine decarboxylase in SENCAR mice by polyphenolic fraction isolated from green tea and its individual epicatechin derivatives.

  1992cited by this paper
• Enhancement of antioxidant and phase II enzymes by oral feeding of green tea polyphenols in drinking water to SKH-1 hairless mice: possible role in cancer chemoprevention.

  1992cited by this paper
• Multistage carcinogenesis in mouse skin.

  1992cited by this paper
• Effect of the flavanolignans of Silybum marianum L. on lipid peroxidation in rat liver microsomes and freshly isolated hepatocytes.

  1992cited by this paper
• Pharmacology of the skin

  1992cited by this paper
• Characterization of effective chemopreventive agents in mammary gland in vitro using an initiation-promotion protocol.

  1991cited by this paper
• Acetaminophen does not induce oxidative stress in isolated rat hepatocytes: its probable antioxidant effect is potentiated by the flavonoid silybin.

  1991cited by this paper
• Protection Against Microcystin-LR-Induced Hepatotoxicity by Silymarin: Biochemistry, Histopathology, and Lethality

  1991cited by this paper
• Effect of the bioflavonoid silymarin on the in vitro activity and expression of superoxide dismutase (SOD) enzyme.

  1991cited by this paper
• Inhibition of carcinogenesis by naturally-occurring and synthetic compounds.

  1990cited by this paper
• Free radicals, antioxidant enzymes, and carcinogenesis.

  1990cited by this paper
• Glutathione S-transferases.

  1990cited by this paper
• Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant.

  1990cited by this paper
• Inhibition of transformation in cultured rat tracheal epithelial cells by potential chemopreventive agents.

  1990cited by this paper
• An antioxidant drug, silibinin, modulates steroid secretion in human pathological adrenocortical cells.

  1990cited by this paper
• Studies on the antioxidant and free radical scavenging properties of IdB 1016 a new flavanolignan complex.

  1990cited by this paper
• PREVENTION OF CCL4‐INDUCED LIVER CIRRHOSIS BY SILYMARIN

  1989cited by this paper
• Antioxidants and multistage carcinogenesis in mouse skin.

  1989cited by this paper
• Selectivity of Silymarin on the Increase of the Glutathione Content in Different Tissues of the Rat

  1989cited by this paper
• Dermatologic therapies you've probably never heard of.

  1989cited by this paper
• Protective effect of flavonoids on drug-induced hepatotoxicity in vitro.

  1989cited by this paper
• Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver.

  1989cited by this paper
• Antioxidant Properties of the Flavonoids Silybin and (+)-Cyanidanol-3: Comparison with Butylated Hydroxyanisole and Butylated Hydroxytoluene

  1986cited by this paper
• Effect of silymarin on chemical, functional, and morphological alterations of the liver. A double-blind controlled study.

  1982cited by this paper
• Skin Cancer

  1980cited by this paper
• Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity.

  1980cited by this paper
• [The chemistry and analysis of silymarin from Silybum marianum Gaertn].

  1974cited by this paper
• Glutathione S-transferases. The first enzymatic step in mercapturic acid formation.

  1974cited by this paper

• Protective role of Silymarin in the mitigation of methotrexate induced biometrical and haemato-biochemical alterations of liver in rabbits

  2026cites this paper
• Silybum marianum seeds mitigate pro-inflammatory functions of human neutrophils and alleviate ulcerative colitis in rats

  2025cites this paper
• Therapeutic potential and mechanistic insights of silibinin targeting cancer-associated fibroblasts in colorectal cancer

  2025cites this paper
• On a deterministic mathematical model which efficiently predicts the protective effect of a plant extract mixture in cirrhotic rats.

  2024cites this paper
• Role of skin enzymes in metabolism of topical drugs

  2024cites this paper
• A critical appraisal of geroprotective activities of flavonoids in terms of their bio-accessibility and polypharmacology.

  2024cites this paper
• Novel Strategies Enhancing Bioavailability and Therapeutical Potential of Silibinin for Treatment of Liver Disorders

  2024cites this paper
• Silybin A from Silybum marianum reprograms lipid metabolism to induce a cell fate-dependent class switch from triglycerides to phospholipids

  2024influential citation
• Clinical Utility of Probiotics Therapy in Managing Mycotoxin Illness.

  2023cites this paper
• Silymarin protects against doxorubicin induced cardiotoxicity by down-regulating topoisomerase IIβ expression in mice

  2023cites this paper
• Modulation of Small-Intestine Morphology in Mice by a Novel Supplement Containing Silybum marianum, Yeast β-Glucan, Prebiotics, and Minerals

  2023cites this paper
• In vitro effects of undifferentiated callus extracts from Plantago major L, Rhodiola rosea L and Silybum marianum L in normal and malignant human skin cells

  2023cites this paper
• An overview of the antioxidant effects of silymarin and its role in reducing the harmful effects of some heavy metals, radiation and nicotine on sperm quality.

  2023cites this paper
• Danshao Shugan Granule therapy for non-alcoholic fatty liver disease

  2022cites this paper
• Role of Silymarin in Cancer Treatment: Facts, Hypotheses, and Questions

  2022cites this paper
• Nanonutraceuticals in Chemotherapy of Infectious Diseases and Cancer

  2022cites this paper
• In vitro Dissolution Testing and Pharmacokinetic Studies of Silymarin Solid Dispersion After Oral Administration to Healthy Pigs

  2022cites this paper
• Spectroscopic analysis, NBO, HOMO and LUMO analysis of anticancer compound Silibinin: experimental and theoretical approach

  2022cites this paper
• Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

  2022cites this paper
• Lung cancer targeting efficiency of Silibinin loaded Poly Caprolactone /Pluronic F68 Inhalable nanoparticles: In vitro and In vivo study

  2022cites this paper
• Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS‐CoV‐2

  2022influential citation
• Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

  2022cites this paper
• Lung Cancer Management with Silibinin: A Historical and Translational Perspective

  2021cites this paper
• Effects of anticancer drugs on the cardiac mitochondrial toxicity and their underlying mechanisms for novel cardiac protective strategies.

  2021cites this paper
• Antiparasitic Effects of Selected Isoflavones on Flatworms

  2021influential citation
• Pharmacological, Biochemical and Therapeutic Potential of Milk Thistle (Silymarin): A Review

  2021cites this paper
• Systematic review of pharmacokinetics and potential pharmacokinetic interactions of flavonolignans from silymarin

  2021cites this paper
• Silymarin (milk thistle extract) as a therapeutic agent in gastrointestinal cancer

  2021cites this paper
• Developing a High-Performance Liquid Chromatography Fast and Accurate Method for Quanti�cation of Silibinin

  2021cites this paper
• Anti-cancer Effects of Silibinin: The Current Status in Cancer Chemoprevention

  2020cites this paper
• Chapter 11: Silymarin

  2020cites this paper
• Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole

  2020influential citation
• Delivery and anti-psoriatic effect of silibinin-loaded polymeric micelles: an experimental study in the psoriatic skin model.

  2020cites this paper
• Dihydro-stilbene gigantol relieves CCl4-induced hepatic oxidative stress and inflammation in mice via inhibiting C5b-9 formation in the liver

  2020cites this paper
• Concentration-dependent effect of silymarin on concanavalin A-stimulated mouse spleen cells in vitro

  2020influential citation
• Silibinin and non-melanoma skin cancers

  2020cites this paper
• Lipid nanoconstructs for superior hepatoprotection: In vitro assessments as predictive tool for in vivo translation.

  2020cites this paper
• MILK THISTLE (SILYBUM MARIANUM): A VALUABLE MEDICINAL PLANT WITH SEVERAL THERAPEUTIC PURPOSES

  2020influential citation
• Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice

  2020cites this paper
• Effect of “Amprolinsyl” and “Amprolium 22%” on morphological indices of blood of turkeys for eumeria invasion

  2019cites this paper
• Developing a high-performance liquid chromatography fast and accurate method for quantification of silibinin

  2019cites this paper
• Intestinal Permeability Study of Clinically Relevant Formulations of Silibinin in Caco-2 Cell Monolayers

  2019cites this paper
• Silymarin protects against high fat diet-evoked metabolic injury by induction of glucagon-like peptide 1 and sirtuin 1

  2019cites this paper
• Evaluating the protective efficacy of Silybum marianum against deltamethrin induced hepatotoxicity in piscine model.

  2019cites this paper
• Antiviral Activities of Silymarin and Derivatives

  2019cites this paper
• Silymarin-loaded nanostructured lipid carrier gel for the treatment of skin cancer.

  2019cites this paper
• Anticancer Attributes of Silibinin: Chemo- and Radiosensitization of Cancer

  2018cites this paper
• Pharmacokinetic Study of Bioactive Flavonoids in the Traditional Japanese Medicine Keigairengyoto Exerting Antibacterial Effects against Staphylococcus aureus

  2018cites this paper
• Silymarin loaded nanostructured lipid carrier: From design and dermatokinetic study to mechanistic analysis of epidermal drug deposition enhancement

  2018cites this paper
• Silibinin Reduces the Impact of Obesity on Invasive Liver Cancer

  2017cites this paper
• Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells

  2017cites this paper
• A review for discovering hepatoprotective herbal drugs with least side effects on kidney

  2017cites this paper
• The Effects of Concomitant use of Silymarin and Chemotherapy on Solid Tumors: A pilot randomized controlled trial

  2017cites this paper
• Silymarin: a potent hepatoprotective agent in poultry industry

  2017cites this paper
• The potential of silymarin for the treatment of hepatic disorders

  2016cites this paper
• Highly bioavailable silibinin nanoparticles inhibit HCV infection

  2016cites this paper
• Protective effects of silymarin against acetaminophen-induced hepatotoxicity and nephrotoxicity in mice

  2016cites this paper
• Enzymatic and Metabolic Transformation of Silybin and its Congeners

  2016cites this paper
• Silibinin in cancer therapy : A promising prospect

  2016cites this paper
• The Pros and the Cons for the Use of Silybin-Rich Oral Formulations in Treatment of Liver Damage (NAFLD in Particular).

  2015cites this paper
• An Overview of Ultraviolet B Radiation-Induced Skin Cancer Chemoprevention by Silibinin

  2015cites this paper
• Silymarin

  2015cites this paper
• Hepatoprotective effect of oral application of a silymarin extract in carbon tetrachloride-induced hepatotoxicity in rats

  2015cites this paper
• Silymarin prevents benzo(a)pyrene-induced toxicity in Wistar rats by modulating xenobiotic-metabolizing enzymes

  2015influential citation
• Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study.

  2015cites this paper
• Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives

  2015cites this paper
• Silymarin: an insight to its formulation and analytical prospects

  2015cites this paper
• Silibinin exerts cancer chemopreventive efficacy via targeting prostate cancer cell and cancer-associated fibroblast interaction

  2015cites this paper
• Silibinin suppresses NPM-ALK, potently induces apoptosis and enhances chemosensitivity in ALK-positive anaplastic large cell lymphoma

  2015cites this paper
• Pharmacokinetics of pure silybin diastereoisomers and identification of their metabolites in rat plasma

  2015cites this paper
• FORMULATION AND EVALUATION OF SILIBININ LOADED SOLID LIPID NANOPARTICLES FOR PERORAL USE TARGETING LOWER PART OF GASTROINTESTINAL TRACT

  2014cites this paper
• Efeito da silibinina sobre parâmetros de estresse oxidativo contra a neurotoxicidade da fenilalanina

  2014cites this paper
• Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.

  2013cites this paper
• Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer

  2013cites this paper
• Hepatoprotective activity of Chhit-Chan-Than extract powder against carbon tetrachloride-induced liver injury in rats

  2013cites this paper
• Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer 71

  2013cites this paper
• The Role of Direct and Indirect Polyphenolic Antioxidants in Protection Against Oxidative Stress

  2013cites this paper
• Evaluation of antioxidant capacity and inflammatory cytokine gene expression in horses fed silibinin complexed with phospholipid.

  2013cites this paper
• Biotransformation of silybin and its congeners.

  2013cites this paper
• The gut-liver axis

  2013cites this paper
• Anti-Inflammatory Efficacy of Silibinin: Role in Cancer Chemoprevention

  2013cites this paper
• Comparative Analysis of the Fatty Acid Pattern of Silybum marianum with Nigella sativa by Gas Chromatography-Mass Spectrometry

  2013cites this paper
• Beneficial role of silibinin in monitoring the cadmium induced hepatotoxicity in Albino Wistar rats

  2012influential citation
• Extraction, identification et caractérisation des molécules bioactives de la graine et de l'huile de Silybum marianum. Étude de leurs activités antioxydante et antitumorale

  2012cites this paper
• Silymarin regulates HIF-1α and iNOS expression in the brain and gills of hypoxic-reoxygenated rainbow trout Oncorhynchus mykiss

  2012cites this paper
• Silibinin (Milk Thistle) potentiates ethanol-dependent hepatocellular carcinoma progression in male mice.

  2012cites this paper
• Limitations of In Vitro Assessments of the Drug Interaction Potential of Botanical Supplements

  2012cites this paper
• Biological analysis of herbal medicines used for the treatment of liver diseases.

  2011influential citation
• Silybin and the liver: from basic research to clinical practice.

  2011cites this paper
• Protection against 2-chloroethyl ethyl sulfide (CEES)-induced cytotoxicity in human keratinocytes by an inducer of the glutathione detoxification pathway.

  2011cites this paper
• Reassessing bioavailability of silymarin.

  2011cites this paper
• Silybin inhibits interleukin-1β-induced production of pro-inflammatory mediators in canine hepatocyte cultures.

  2011cites this paper
• Flavonoids and alkenylbenzenes: New concepts in bioactivation studies.

  2011cites this paper
• Silibinin inhibits the invasion and migration of renal carcinoma 786‐O cells in vitro, inhibits the growth of xenografts in vivo and enhances chemosensitivity to 5‐fluorouracil and paclitaxel

  2011cites this paper
• Targeting silibinin in the antiproliferative pathway

  2010cites this paper
• Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.

  2010cites this paper
• Silibinin--a promising new treatment for cancer.

  2010cites this paper
• Preparation and evaluation of galactosylated vesicular carrier for hepatic targeting of silibinin

  2010cites this paper
• Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR‐dependent signaling

  2010cites this paper
• Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.

  2010cites this paper